StonvexLoading…
StonvexStonvexStonvexCore line items from IZEA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.57M | $31.24M | $25.17M | $17.10M |
Operating Income | $-1.17M | $-1.86M | $-248.46K | $81.96K |
Net Income | $-777.52K | $42.33K | $1.21M | $1.06M |
EPS (Diluted) | $-0.04 | $0.00 | $0.07 | $0.06 |
Total Assets | $55.54M | $57.48M | $57.87M | $59.63M |
Total Liabilities | $7.07M | $8.56M | $8.00M | $10.25M |
Cash & Equivalents | $46.50M | $50.89M | $51.39M | $50.64M |
Free Cash Flow OCF − CapEx | Not available | $2.37M | Not available | $1.22M |
Shares Outstanding | 17.36M | 17.26M | 17.04M | 16.91M |